ASSOCIATION BETWEEN SMOKING AND THE ANTIPLATELET EFFECT OF CLOPIDOGREL
Clopidogrel is the most widely used P2Y12 inhibitor, which is administered for secondary prevention of atherothrombotic events in patients with cardiovascular disease after myocardial infarction and coronary stenting. Given the complexity of the clopidogrel metabolism and variety of potential drug-d...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Scientia Publishing House
2020-10-01
|
| Series: | Juvenis Scientia |
| Subjects: | |
| Online Access: | https://en.jscientia.org/2020-6-5-02 |